| The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence CA Heidbreder, EL Gardner, ZX Xi, PK Thanos, M Mugnaini, JJ Hagan, ... Brain Research Reviews 49 (1), 77-105, 2005 | 340 | 2005 |
| Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area α6β2* receptors in mediating systemic nicotine effects on dopamine release … C Gotti, S Guiducci, V Tedesco, S Corbioli, L Zanetti, M Moretti, A Zanardi, ... Journal of neuroscience 30 (15), 5311-5325, 2010 | 269 | 2010 |
| The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection C Corti, G Battaglia, G Molinaro, B Riozzi, A Pittaluga, M Corsi, ... Journal of Neuroscience 27 (31), 8297-8308, 2007 | 226 | 2007 |
| Imaging dopamine D3 receptors in the human brain with positron emission tomography,[11C] PHNO, and a selective D3 receptor antagonist G Searle, JD Beaver, RA Comley, M Bani, A Tziortzi, M Slifstein, ... Biological psychiatry 68 (4), 392-399, 2010 | 165 | 2010 |
| Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site R Di Fabio, AM Capelli, N Conti, A Cugola, D Donati, A Feriani, P Gastaldi, ... Journal of medicinal chemistry 40 (6), 841-850, 1997 | 110 | 1997 |
| 1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists F Micheli, G Bonanomi, FE Blaney, S Braggio, AM Capelli, A Checchia, ... Journal of Medicinal Chemistry 50 (21), 5076-5089, 2007 | 106 | 2007 |
| Upregulation of [3H] methyllycaconitine binding sites following continuous infusion of nicotine, without changes of α7 or α6 subunit mRNA: an autoradiography and in situ … M Mugnaini, M Tessari, G Tarter, E Merlo Pich, C Chiamulera, ... European Journal of Neuroscience 16 (9), 1633-1646, 2002 | 106 | 2002 |
| Occupancy of brain dopamine D3 receptors and drug craving: a translational approach M Mugnaini, L Iavarone, P Cavallini, C Griffante, B Oliosi, C Savoia, ... Neuropsychopharmacology 38 (2), 302-312, 2013 | 94 | 2013 |
| Selective down-regulation of [125I] Y0-α-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine M Mugnaini, M Garzotti, I Sartori, M Pilla, P Repeto, CA Heidbreder, ... Neuroscience 137 (2), 565-572, 2006 | 77 | 2006 |
| Dopamine responsiveness to drugs of abuse: a shell‐core investigation in the nucleus accumbens of the mouse A Zocchi, E Girlanda, G Varnier, I Sartori, L Zanetti, GA Wildish, M Lennon, ... Synapse 50 (4), 293-302, 2003 | 74 | 2003 |
| 1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3 Receptor Antagonists F Micheli, L Arista, G Bonanomi, FE Blaney, S Braggio, AM Capelli, ... Journal of medicinal chemistry 53 (1), 374-391, 2010 | 66 | 2010 |
| Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A M Quartaroli, C Carignani, G Dal Forno, M Mugnaini, A Ugolini, R Arban, ... Journal of Pharmacology and Experimental Therapeutics 290 (1), 158-169, 1999 | 66 | 1999 |
| A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor … M Moretti, M Mugnaini, M Tessari, M Zoli, A Gaimarri, I Manfredi, F Pistillo, ... Molecular pharmacology 78 (2), 287-296, 2010 | 65 | 2010 |
| Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists AM Capelli, L Castelletti, YH Chen, H Van der Keyl, L Pucci, B Oliosi, ... British journal of pharmacology 163 (2), 313-329, 2011 | 38 | 2011 |
| 3‐[(±)‐2‐Carboxypiperazin‐4‐yl] propyl‐1‐Phosphonic Acid Recognizes Two N‐Methyl‐D‐Aspartate Binding Sites in Rat Cerebral Cortex Membranes FTM van Amsterdam, A Giberti, M Mugnaini, E Ratti Journal of neurochemistry 59 (5), 1850-1855, 1992 | 34 | 1992 |
| Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice E Vicentini, R Arban, O Angelici, G Maraia, ME Perico, M Mugnaini, ... Pharmacology Biochemistry and Behavior 93 (1), 17-24, 2009 | 30 | 2009 |
| Regionally different N‐methyl‐D‐aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]‐CGP 39653 in rat brain M Mugnaini, FTM van Amsterdam, E Ratti, DG Trist, NG Bowery British journal of pharmacology 119 (5), 819-828, 1996 | 29 | 1996 |
| [3H] MK-801 binding and the mRNA for the NMDAR1 subunit of the NMDA receptor are differentially distributed in human and rat forebrain P Meoni, M Mugnaini, BH Bunnemann, DG Trist, NG Bowery Molecular brain research 54 (1), 13-23, 1998 | 25 | 1998 |
| Allosteric Modulation of [3H]CGP 39653 Binding by Glycine in Rat Brain M Mugnaini, A Giberti, E Ratti, FTM van Amsterdam Journal of neurochemistry 61 (4), 1492-1497, 1993 | 25 | 1993 |
| [3H] 5, 7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes M Mugnaini, M Antolini, M Corsi, FTM Van Amsterdam Journal of Receptors and Signal Transduction 18 (2-3), 91-112, 1998 | 22 | 1998 |
